Thrivent Financial for Lutherans
Position in RCUS — Arcus Biosciences, Inc.
CIK 314984
Minneapolis, MN
Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,426,875
+$917,575 QoQ
Shares Held
78,718
+12.7% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 230 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $349,109,213 across 50 Biotechnology names. RCUS ranks #20 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,620,743 | $88,184,625 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
131,457 | $81,968,697 | |
| 3 | RPRX |
Royalty Pharma plc
|
740,772 | $41,535,085 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
80,500 | $19,398,084 | |
| 5 | ARGX |
Argenx SE
|
12,688 | $11,771,545 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,169 | $10,018,546 | |
| 7 | VCEL |
Vericel Corp
|
170,272 | $7,575,400 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
17,229 | $6,403,502 |
All Filings in RCUS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,426,875 | 78,718 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,509,300 | 69,875 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,915,764 | 80,393 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $678,762 | 49,909 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $405,616 | 49,830 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $388,017 | 49,429 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $621,404 | 41,733 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $647,684 | 42,360 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $689,964 | 45,303 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $885,377 | 46,895 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $917,296 | 48,026 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $880,842 | 49,072 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,022,669 | 50,353 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $942,369 | 51,665 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,105,883 | 53,476 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,404,975 | 53,707 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,160,546 | 45,799 | Shares | Sole | 2022-08-16 | |
| No filing history on record for this holder in this stock. | ||||||